165 related articles for article (PubMed ID: 18486101)
1. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Hara A; Hu R; Li G; Li Y; Nakamura K; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2008 Jul; 76(1):108-19. PubMed ID: 18486101
[TBL] [Abstract][Full Text] [Related]
2. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic acid lowers plasma and liver cholesterol levels in the presence of peroxisome proliferators-activated receptor alpha.
Sugiyama E; Ishikawa Y; Li Y; Kagai T; Nobayashi M; Tanaka N; Kamijo Y; Yokoyama S; Hara A; Aoyama T
Life Sci; 2008 Jul; 83(1-2):19-28. PubMed ID: 18541273
[TBL] [Abstract][Full Text] [Related]
4. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.
Niho N; Takahashi M; Kitamura T; Shoji Y; Itoh M; Noda T; Sugimura T; Wakabayashi K
Cancer Res; 2003 Sep; 63(18):6090-5. PubMed ID: 14522940
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.
Oishi K; Koyanagi S; Matsunaga N; Kadota K; Ikeda E; Hayashida S; Kuramoto Y; Shimeno H; Soeda S; Ohdo S
Mol Pharmacol; 2010 Jul; 78(1):135-41. PubMed ID: 20400680
[TBL] [Abstract][Full Text] [Related]
6. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.
Oishi K; Uchida D; Ishida N
FEBS Lett; 2008 Oct; 582(25-26):3639-42. PubMed ID: 18840432
[TBL] [Abstract][Full Text] [Related]
7. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
8. Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver.
Bonilla S; Redonnet A; Noël-Suberville C; Groubet R; Pallet V; Higueret P
J Physiol Biochem; 2001 Mar; 57(2):1-8. PubMed ID: 11579993
[TBL] [Abstract][Full Text] [Related]
9. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
Roglans N; Bellido A; Rodríguez C; Cabrero A; Novell F; Ros E; Zambón D; Laguna JC
Clin Pharmacol Ther; 2002 Dec; 72(6):692-701. PubMed ID: 12496750
[TBL] [Abstract][Full Text] [Related]
10. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.
LoVerme J; Russo R; La Rana G; Fu J; Farthing J; Mattace-Raso G; Meli R; Hohmann A; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2006 Dec; 319(3):1051-61. PubMed ID: 16997973
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of peroxisome proliferator-activated receptor alpha and liver fatty acid binding protein after partial hepatectomy of rats and mice.
Skrtic S; Carlsson L; Ljungberg A; Lindén D; Michalik L; Wahli W; Oscarsson J
Liver Int; 2005 Feb; 25(1):33-40. PubMed ID: 15698396
[TBL] [Abstract][Full Text] [Related]
12. Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.
Nakajima T; Tanaka N; Kanbe H; Hara A; Kamijo Y; Zhang X; Gonzalez FJ; Aoyama T
Mol Pharmacol; 2009 Apr; 75(4):782-92. PubMed ID: 19124612
[TBL] [Abstract][Full Text] [Related]
13. PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis.
Koch A; König B; Stangl GI; Eder K
Exp Biol Med (Maywood); 2008 Mar; 233(3):356-65. PubMed ID: 18296741
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiling of the molar tooth germ in peroxisome proliferator-activated receptor-alpha (PPAR-alpha) knockout mouse and in wild-type mouse: molar tooth phenotype of PPAR-alpha knockout mouse.
Sehic A; Khuu C; Risnes S; Osmundsen H
Eur J Oral Sci; 2009 Apr; 117(2):93-104. PubMed ID: 19320717
[TBL] [Abstract][Full Text] [Related]
15. Effects of fish oil and conjugated linoleic acids on expression of target genes of PPAR alpha and sterol regulatory element-binding proteins in the liver of laying hens.
König B; Spielmann J; Haase K; Brandsch C; Kluge H; Stangl GI; Eder K
Br J Nutr; 2008 Aug; 100(2):355-63. PubMed ID: 18205990
[TBL] [Abstract][Full Text] [Related]
16. Effect of peroxisome proliferator-activated receptor-alpha agonist (bezafibrate) on gastric secretion and gastric cytoprotection in rats.
Pathak R; Asad M; Hrishikeshavan HJ; Prasad S
Fundam Clin Pharmacol; 2007 Jun; 21(3):291-6. PubMed ID: 17521298
[TBL] [Abstract][Full Text] [Related]
17. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.
Hiuge A; Tenenbaum A; Maeda N; Benderly M; Kumada M; Fisman EZ; Tanne D; Matas Z; Hibuse T; Fujita K; Nishizawa H; Adler Y; Motro M; Kihara S; Shimomura I; Behar S; Funahashi T
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):635-41. PubMed ID: 17194889
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
20. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.
Nakamachi T; Nomiyama T; Gizard F; Heywood EB; Jones KL; Zhao Y; Fuentes L; Takebayashi K; Aso Y; Staels B; Inukai T; Bruemmer D
Diabetes; 2007 Jun; 56(6):1662-70. PubMed ID: 17360982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
